Dr. Tehmina Zafar, MD

Dr. Zafar practices at Southeast Health Medical Center in Dothan, Alabama, part of Houston County Health Care Authority.

Dr. Zafar's NPI, 1548824303, was assigned on April 26, 2019. Dr. Zafar graduated from Avalon University School of Medicine in 2018. Dr. Zafar holds Alabama license 44670.

Dr. Zafar's primary practice is Southeast Health Medical Center, at 1108 Ross Clark Circle, Dothan, AL 36301 in Houston County. The practice phone is (334) 793-8701.

Dr. Zafar's primary practice is Southeast Health Medical Center in Dothan, Alabama, part of Houston County Health Care Authority. The medical group on file is Southeast Health Enterprise Clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zafar practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Zafar's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Zafar is licensed in Alabama.

Dmand AI lists acute respiratory failure, bile duct problems, cardiac arrhythmia, congestive heart failure, electrolyte disorders, gastrointestinal bleeding, gastrointestinal inflammation and heart attack among the conditions Dr. Zafar treats.

CMS data shows 713 Medicare services from Dr. Zafar across 6 procedure codes in 2024, for 228 Medicare patients. Medicare paid $48,115 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 228 Medicare patients who saw Dr. Zafar in 2024. The largest group is 75 to 84, with 79 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zafar's median patient age at 72, with 52% women.

In 2024, Dr. Zafar wrote 308 Medicare Part D claims for 124 patients. 82% of them were for generic drugs. CMS names the drug for 61 of them, across 5 drugs with 11 or more claims each, at $7,944 in total drug cost. In 2023, CMS named 130 claims across 8 drugs.

Dr. Zafar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Zafar in 2018. 2018 was the busiest year, with 2. Dr. Zafar has published most often in Cureus. Dr. Zafar's most frequent co-authors are Waliul Chowdhury, MD, Hasnan Moavia Ijaz, MD and Ahmad Ayman Khiami, MD.

CMS Open Payments shows 17 general payments to Dr. Zafar from 9 drug and device companies from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $107.

Dr. Zafar graduated from Avalon University School of Medicine in 2018.

Dr. Zafar is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.